This inventor holds 8 USPTO granted patents and 9 published patent applications, plus 1 CIPO patent and 6 EPO patents. Top assignees: Curevac Ag, Curevac Manufacturing Gmbh, Curevac Real Estate Gmbh. Active years: 2020-2026.
Company Filing History:
2 out of 97 
2 out of 11 
2 out of 9 Years Active: 2020-2026
Title: Aniela Wochner: Innovator in RNA Technology
Introduction
Aniela Wochner is a prominent inventor based in Tübingen, Germany. She has made significant contributions to the field of RNA technology, holding a total of 8 patents. Her work focuses on innovative solutions for RNA in vitro transcription and analysis.
Latest Patents
One of her latest patents is a bioreactor for RNA in vitro transcription. This invention relates to a bioreactor designed for RNA in vitro transcription, a method for RNA in vitro transcription, and an automated apparatus for RNA manufacturing. The bioreactor allows for the repetitive use of DNA templates for various RNA in vitro transcription reactions under GMP-compliant conditions. Another notable patent involves RNA analysis by total hydrolysis and quantification of released nucleosides, which is essential for quality control of RNA molecules produced by in vitro transcription or chemical synthesis.
Career Highlights
Aniela has worked with notable companies such as Curevac Real Estate GmbH and Curevac AG. Her experience in these organizations has contributed to her expertise in RNA technology and innovation.
Collaborations
Aniela has collaborated with talented individuals in her field, including Tilmann Roos and Benyamin Yazdan Panah. These collaborations have further enhanced her research and development efforts.
Conclusion
Aniela Wochner is a trailblazer in RNA technology, with a strong portfolio of patents and a commitment to advancing the field. Her innovative work continues to impact the scientific community and beyond.